92 related articles for article (PubMed ID: 33053933)
1. The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC).
Kim DJ; Jeong WI; Tsukamoto H; Gao B
Clin Mol Hepatol; 2020 Oct; 26(4):584-585. PubMed ID: 33053933
[No Abstract] [Full Text] [Related]
2. Proceedings of the International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis, 18-19 May 2006, Marina del Rey, California, USA.
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S1-110. PubMed ID: 16958656
[No Abstract] [Full Text] [Related]
3. Proceedings of the 6th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis, October 20-21, 2011, Fukuoka, Japan.
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():10-139. PubMed ID: 22670266
[No Abstract] [Full Text] [Related]
4. Proceedings of the 2nd International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis. October 18-19, 2007. Kobe, Japan.
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S1-128. PubMed ID: 18756615
[No Abstract] [Full Text] [Related]
5. 2nd International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis, 18-19 October 2007, Kobe, Japan. Preface.
Atomi Y; Arii S
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S1. PubMed ID: 18336650
[No Abstract] [Full Text] [Related]
6. A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic.
Bossi MM; Tufoni M; Zaccherini G; Antognoli A; Domenicali M; Caraceni P
Dig Liver Dis; 2020 Sep; 52(9):956-957. PubMed ID: 32513630
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
8. With Alcohol as the Fuel, COVID Is the Match: Liver Transplantation for Alcohol-Associated Liver Disease Is Increasing in the United States.
Bloom PP; Fontana RJ
Hepatology; 2021 Dec; 74(6):2948-2951. PubMed ID: 34496063
[No Abstract] [Full Text] [Related]
9. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis.
Mawson AR; Croft AM; Gonzalez-Fernandez F
Viral Immunol; 2021; 34(6):376-379. PubMed ID: 33983857
[TBL] [Abstract][Full Text] [Related]
10. Response to: 'No impact of Covid-19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan'.
Gonzalez HC; Rupp LB; Trudeau S; Gordon SC
Liver Int; 2022 Aug; 42(8):1910-1911. PubMed ID: 35670429
[No Abstract] [Full Text] [Related]
11. COVID-19 in patients with cirrhosis: understanding adverse impact.
Sharma S; Elhence A; Vaishnav M; Kumar R; Shalimar
Gut; 2021 Jul; 70(7):1409. PubMed ID: 32826307
[No Abstract] [Full Text] [Related]
12. Reply to: Correspondence on "High rates of 30-day mortality in patients with cirrhosis and COVID-19".
Iavarone M; D'Ambrosio R; Lampertico P;
J Hepatol; 2020 Dec; 73(6):1570-1571. PubMed ID: 32771429
[No Abstract] [Full Text] [Related]
13. A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.
Gambato M; Germani G; Perini B; Gringeri E; Feltracco P; Plebani M; Burra P; Russo FP
Transpl Int; 2021 Apr; 34(4):756-757. PubMed ID: 33556199
[No Abstract] [Full Text] [Related]
14. Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous With Injury or Noise?
Ashok A; Faghih M; Singh VK
Gastroenterology; 2021 Apr; 160(5):1872. PubMed ID: 32544396
[No Abstract] [Full Text] [Related]
15. Correspondence on "prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection".
Mungmunpuntipantip R; Wiwanitkit V
Ann Hepatol; 2021; 25():100360. PubMed ID: 34119682
[No Abstract] [Full Text] [Related]
16. Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Lampertico P
Gut; 2021 Sep; 70(9):1798-1799. PubMed ID: 33028665
[No Abstract] [Full Text] [Related]
17. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.
Xiao Y; Pan H; She Q; Wang F; Chen M
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):528-529. PubMed ID: 32197093
[No Abstract] [Full Text] [Related]
18. Pancreatic fibrosis in patients with alcoholic dependence syndrome.
Suda K; Akai J; Nakamura T
Arch Pathol Lab Med; 1993 Oct; 117(10):1013-6. PubMed ID: 8215822
[TBL] [Abstract][Full Text] [Related]
19. Letter regarding "High rates of 30-day mortality in patients with cirrhosis and COVID-19".
Medhat MA; El Kassas M
J Hepatol; 2020 Dec; 73(6):1569-1570. PubMed ID: 32574577
[No Abstract] [Full Text] [Related]
20. Reply to: "Liver fibrosis and adverse outcomes in COVID-19".
Ruiz-Margáin A; Campos-Murguía A; González-Regueiro JA; Román-Calleja BM; Delint DK; Macías-Rodríguez RU
Dig Liver Dis; 2021 Jul; 53(7):800. PubMed ID: 33947641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
